923 related articles for article (PubMed ID: 12756386)
1. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?
Hannon TS; Noonan K; Steinmetz R; Eugster EA; Levine MA; Pescovitz OH
J Pediatr; 2003 May; 142(5):532-8. PubMed ID: 12756386
[TBL] [Abstract][Full Text] [Related]
2. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.
Leet AI; Chebli C; Kushner H; Chen CC; Kelly MH; Brillante BA; Robey PG; Bianco P; Wientroub S; Collins MT
J Bone Miner Res; 2004 Apr; 19(4):571-7. PubMed ID: 15005844
[TBL] [Abstract][Full Text] [Related]
3. Activating mutations of Gs protein in monostotic fibrous lesions of bone.
Alman BA; Greel DA; Wolfe HJ
J Orthop Res; 1996 Mar; 14(2):311-5. PubMed ID: 8648511
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and molecular study of Chilean patients with McCune-Albright syndrome].
Román R; Johnson MC; Codner E; Cattani A; García H; Mericq V; Boric A; Muñoz M; Schneider R; Cassorla F
Rev Med Chil; 2001 Dec; 129(12):1365-72. PubMed ID: 12080873
[TBL] [Abstract][Full Text] [Related]
5. GNAS mutation detection is related to disease severity in girls with McCune-Albright syndrome and precocious puberty.
Wagoner HA; Steinmetz R; Bethin KE; Eugster EA; Pescovitz OH; Hannon TS
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():395-400. PubMed ID: 17982386
[TBL] [Abstract][Full Text] [Related]
6. [Pseudo precocious puberty in the McCune-Albright syndrome].
Bost M; Andrini P; Jean D
Pediatrie; 1985; 40(1):55-60. PubMed ID: 4022718
[TBL] [Abstract][Full Text] [Related]
7. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study.
Cho EK; Kim J; Yang A; Ki CS; Lee JE; Cho SY; Jin DK
Orphanet J Rare Dis; 2016 Aug; 11(1):113. PubMed ID: 27506760
[TBL] [Abstract][Full Text] [Related]
8. McCune Albright Syndrome (MCAS): a case series.
Rao S; Colaco MP; Desai MP
Indian Pediatr; 2003 Jan; 40(1):29-35. PubMed ID: 12554915
[TBL] [Abstract][Full Text] [Related]
9. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
[TBL] [Abstract][Full Text] [Related]
10. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.
Weinstein LS; Shenker A; Gejman PV; Merino MJ; Friedman E; Spiegel AM
N Engl J Med; 1991 Dec; 325(24):1688-95. PubMed ID: 1944469
[TBL] [Abstract][Full Text] [Related]
11. Isolated Cushing's syndrome: an unusual presentation of McCune-Albright syndrome in the neonatal period.
Paris F; Philibert P; Lumbroso S; Servant N; Kalfa N; Sultan C
Horm Res; 2009; 72(5):315-9. PubMed ID: 19844118
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial.
Eugster EA; Rubin SD; Reiter EO; Plourde P; Jou HC; Pescovitz OH;
J Pediatr; 2003 Jul; 143(1):60-6. PubMed ID: 12915825
[TBL] [Abstract][Full Text] [Related]
13. McCune-Albright syndrome: radiological and MR findings.
Yongjing G; Huawei L; Zilai P; Bei D; Hao J; Kemin C
JBR-BTR; 2001; 84(6):250-2. PubMed ID: 11817476
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
Stanton RP; Hobson GM; Montgomery BE; Moses PA; Smith-Kirwin SM; Funanage VL
J Bone Miner Res; 1999 Jul; 14(7):1104-14. PubMed ID: 10404010
[TBL] [Abstract][Full Text] [Related]
15. Fibrous dysplasia of bone and McCune-Albright syndrome.
Chapurlat RD; Orcel P
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):55-69. PubMed ID: 18328981
[TBL] [Abstract][Full Text] [Related]
16. [Acromegaly associated with McCune-Albright syndrome].
Tóth M; Töke J; Kiss E; Bernád I; Miheller P; Szücs N; Rácz K
Orv Hetil; 2002 May; 143(19 Suppl):1070-3. PubMed ID: 12063863
[TBL] [Abstract][Full Text] [Related]
17. A case of McCune-Albright syndrome associated with Gs alpha mutation in the bone tissue.
Sargin H; Gozu H; Bircan R; Sargin M; Avsar M; Ekinci G; Yayla A; Gulec I; Bozbuga M; Cirakoglu B; Tanakol R
Endocr J; 2006 Feb; 53(1):35-44. PubMed ID: 16543670
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.
Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone.
Bianco P; Riminucci M; Majolagbe A; Kuznetsov SA; Collins MT; Mankani MH; Corsi A; Bone HG; Wientroub S; Spiegel AM; Fisher LW; Robey PG
J Bone Miner Res; 2000 Jan; 15(1):120-8. PubMed ID: 10646121
[TBL] [Abstract][Full Text] [Related]
20. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations.
Collins MT; Sarlis NJ; Merino MJ; Monroe J; Crawford SE; Krakoff JA; Guthrie LC; Bonat S; Robey PG; Shenker A
J Clin Endocrinol Metab; 2003 Sep; 88(9):4413-7. PubMed ID: 12970318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]